PL1740204T3 - Lecznicze zastosowanie alfa-mannozydazy - Google Patents

Lecznicze zastosowanie alfa-mannozydazy

Info

Publication number
PL1740204T3
PL1740204T3 PL05715146T PL05715146T PL1740204T3 PL 1740204 T3 PL1740204 T3 PL 1740204T3 PL 05715146 T PL05715146 T PL 05715146T PL 05715146 T PL05715146 T PL 05715146T PL 1740204 T3 PL1740204 T3 PL 1740204T3
Authority
PL
Poland
Prior art keywords
mannosidase
alpha
medicinal use
medicinal
Prior art date
Application number
PL05715146T
Other languages
English (en)
Inventor
Claes Andersson
Jens Fogh
Cecilia Weigelt
Diego Prieto Roces
Kurt Von Figura
Meher Irani
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of PL1740204T3 publication Critical patent/PL1740204T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01024—Alpha-mannosidase (3.2.1.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
PL05715146T 2004-04-01 2005-04-01 Lecznicze zastosowanie alfa-mannozydazy PL1740204T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55810804P 2004-04-01 2004-04-01
DKPA200400528 2004-04-01
EP05715146.6A EP1740204B1 (en) 2004-04-01 2005-04-01 Medicinal use of alpha-mannosidase
PCT/DK2005/000228 WO2005094874A1 (en) 2004-04-01 2005-04-01 Medical use of alpha-mannosidase

Publications (1)

Publication Number Publication Date
PL1740204T3 true PL1740204T3 (pl) 2018-08-31

Family

ID=34962870

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05715146T PL1740204T3 (pl) 2004-04-01 2005-04-01 Lecznicze zastosowanie alfa-mannozydazy

Country Status (5)

Country Link
EP (1) EP1740204B1 (pl)
DK (1) DK1740204T3 (pl)
PL (1) PL1740204T3 (pl)
SI (1) SI1740204T1 (pl)
WO (1) WO2005094874A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
JP4586027B2 (ja) 2004-01-30 2010-11-24 シャイア ファーマシューティカルズ アイルランド リミテッド 組換えアリールスルファターゼａの製造及び精製
MY145870A (en) * 2005-12-15 2012-05-15 Lilly Co Eli Enzymes for reduced immunological stress
MX2008012748A (es) 2006-04-04 2009-01-07 Shire Pharmaceuticals Ireland Un proceso para la concentracion de un polipeptido.
CN102978185B (zh) 2007-01-18 2015-02-11 建新公司 包含氨基氧基基团的寡糖及其轭合物
WO2008089339A2 (en) * 2007-01-18 2008-07-24 Genzyme Corporation Oligosaccharide conjugates for cellular targeting
PL2889043T3 (pl) 2008-12-16 2019-09-30 Genzyme Corporation Syntetyczne związki pośrednie do wytwarzania koniugatów oligosacharyd-białko
NZ601790A (en) * 2010-02-24 2014-03-28 Zymenex As Process for production and purification of recombinant lysosomal alpha-mannosidase
EP2729566B1 (en) 2011-07-08 2017-03-15 Shire Human Genetic Therapies, Inc. Methods for purification of arylsulfatase a
EP2943568B1 (en) 2013-01-09 2019-11-20 Shire Human Genetic Therapies, Inc. Methods for purification of arylsulfatase a

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073482A1 (en) * 1999-05-28 2000-12-07 Chiron Corporation Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
WO2002099092A2 (en) * 2001-06-07 2002-12-12 Hemebiotech A/S Production of recombinant human lysosomal alpha-mannosidase

Also Published As

Publication number Publication date
EP1740204A1 (en) 2007-01-10
SI1740204T1 (en) 2018-07-31
WO2005094874A1 (en) 2005-10-13
DK1740204T3 (en) 2018-05-22
EP1740204B1 (en) 2018-03-14

Similar Documents

Publication Publication Date Title
IL176958A0 (en) Compounds and methods of use
SI1802579T1 (sl) Derivati 3-arilaminopiridina
EP1785131A4 (en) EXTERNAL PREPARATION OF TYPE S / O
IL173478A0 (en) Form of administration secured against misuse
IL212985A0 (en) Therapeutic uses of inhibitors of rtp801
GB0421149D0 (en) Preparation of oxycodone
GB0305150D0 (en) Use of therapeutic compounds
ZA200407609B (en) Use of vitamin d compounds
EP1796676A4 (en) TRANSDERMALE ADMINISTRATION OF PHYCOTOXINES
EP1757282A4 (en) USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS
EP1812451A4 (en) COMPOUNDS AND METHODS OF USE THEREOF
EP1740541A4 (en) THERAPEUTIC FORMULATIONS OF DESOXYEPOTHILONES
IL180316A0 (en) Quinolone-containing medicinal composition
IL180487A0 (en) Medicament
LT1740204T (lt) Medicininis alfa-manozidazės panaudojimas
GB2415909B (en) Medical Aid
ZA200505214B (en) Preparation of quinapril hydrochloride
GB2406659B (en) Medical clock
GB0426942D0 (en) Medicament
GB0409098D0 (en) Medicament
GB0412882D0 (en) New formulation of eletriptan
HU0400952D0 (en) Treatment of anus-cancer
GB0408959D0 (en) Therapeutic agent
GB0420429D0 (en) Treatment of coccidiosis
GB0421767D0 (en) Compounds and their medical uses